0001140361-23-006075.txt : 20230210 0001140361-23-006075.hdr.sgml : 20230210 20230210184042 ACCESSION NUMBER: 0001140361-23-006075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230208 FILED AS OF DATE: 20230210 DATE AS OF CHANGE: 20230210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Siurek Ryan H CENTRAL INDEX KEY: 0001476512 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39659 FILM NUMBER: 23614015 MAIL ADDRESS: STREET 1: 6200 SPRINT PARKWAY CITY: OVERLAND PARK STATE: KS ZIP: 66251 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODESIX INC CENTRAL INDEX KEY: 0001439725 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 203986492 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-417-0500 MAIL ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 4 1 form4.xml X0306 4 2023-02-08 0001439725 BIODESIX INC BDSX 0001476512 Siurek Ryan H 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 true Chief Accounting Officer Common Stock 2023-02-08 4 M 0 5483 A 29177 D Common Stock 2023-02-09 4 S 0 2016 1.7991 D 27161 D Restricted Stock Units 2023-02-08 4 A 0 82031 0 A Common Stock 82031 82031 D Restricted Stock Units 2023-02-08 4 M 0 1927 0 D Common Stock 1927 23120 D Restricted Stock Units 2023-02-08 4 M 0 3556 0 D Common Stock 3556 7114 D Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock. These shares of Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. /s/ Robin H. Cowie as Attorney-in-Fact for Ryan H. Siurek 2023-02-10